Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Not available.

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Michael J. Hochman, Amy S. Ruppert, Ying Huang, Alice Mims, Uma Borate, Ronan Swords, Elie Traer, Maria R. Baer, Vu H. Duong, Wendy Stock, Toyosi Odenike, Prapti Patel, Yazan Madanat, Eytan Stein, Michael W. Deininger, Gary Schiller, Daniel A. Pollyea, James M. Foran, Rebecca Olin, Tara Lin, Michael M. Boyiadzis, Shivani Handa, Bjoern Rueter, Theophilus J. Gana, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Amy Burd, Ashley O. Yocum, John C. Byrd, William Blum
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Ferrata Storti Foundation 2026-04-01
Seri Bilgileri:	Haematologica
Online Erişim:	https://haematologica.org/article/view/14149
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller